AGE-RELATED LEFT VENTRICLE MYOCARDIAL REMODELING: IS THERE A LINK WITH NORMAL AGEING?

Aim. To study the age-related changes in structure of myocardium of the left ventricle and their relation with telomere length. With the age even in absence of cardiovascular diseases (CVD) and risk factors (CRF) there is a changing of the left ventricle (LV) myocardium structure. Probable mechanism of the age-related changes is cell ageing. One of the markers of cell ageing is telomere length (TL) that is also a marker of biological age. Material and methods. After screening we included 303 persons at the age 23-91 y.o. without clinical signs of CVD. All participants underwent transthoracal echocardiography by the standard method. Telomere length was measured in leucocytes on the genomic desoxyribonucleic acid (DNA) by real-time polymerase chain reaction method (PCR). We measured the relative length of telomeres. For the assessment of parameters relations we used correlational logistic regression analysis and build-up of multidimensional regression models. Results. Older age group (women >55 years and men >45 years) of those without significant signs of CVD and CRF comparing to the group of younger persons we found thicker LV myocardium and its concentric remodeling. TL was significantly linked with the age (β=-0,012, p=0,0001). Also we found the relation of TL with LV structure parameters: interventricular septum thickness (IVST) (β=-0,028, p=0,01), relative wall thickness (RVT) (β=-0,012, p=0,02) using the age and CRF. However shorter telomeres (<9,75 units) were not related to the increase of IVST (OR=1,44; 95% CI 0,84-2,47; p=0,18), posterior wall thickness (PWT) (OR=1,56; 95% CI 0,37-6,59; p=0,55) and RVT (HR=1,40; 95% CI 0,74-2,65; p=0,31). Conclusion. Left ventricle hypertrophy and its concentric remodeling in older age group without CVD and CRF shall be regarded as age-related. LT, cell ageing marker, is not related to the age-specific changes of LV structure.

telomere length, myocardial remodeling, ageing changes

1. Wong LS, van der Harst P, de Boer RA, et al. Aging, telomeres and heart failure. Heart Fail Rev 2010; 15 (5): 479-86.

2. Bernhard D, Laufer G. The aging cardiomyocyte: a mini-review. Gerontology 2008; 54(1): 24-31.

3. Olovnikov AM. Principle of marginotomii in template synthesis of polynucleotides. Report of the Academy of Sciences 1971; v. 201: 1496-9). Russian (Оловников А.М. Принцип маргинотомии в матричном синтезе полинуклеотидов. Докл Акад наук 1971; т. 201: 1496-9).

4. Terai M, Izumiyama-Shimomura N, Aida J, et al. Association of telomere shortening in myocardium with heart weight gain and cause of death. Scientific Reports 2013; 3: 2401. p.1-8.

5. Daniali L, Benetos A, Susser E, et al. Telomeres shorten at equivalent rates in somatic tissues of adults. NatCommun 2013; 4: 1597.

6. Müezzinler A, Zaineddin AK, Brenner H. A systematic review of leukocyte telomere length and age in adults. Ageing Res Rev 2013; 12(2): 509-19.

7. Fyhrquist F, Saijonmaa O. Telomere length and cardiovascular aging. Annals of medicine. 2012; 44 (Suppl 1): S138-42.

8. Epel ES, Merkin SS, Cawthon R, et al. The rate of leukocyte telomere shortening predicts mortality from cardiovascular disease in elderly men. Aging (Albany NY) 2008; 1(1): 81-8.

9. Cawthon RM. Telomere measurement by quantitative PCR. Nucleic Acids Res 2002; 30(10): e47.

10. Vasyuk YA, Hadzegova AB, Krikunov PV, et al. The possibilities and limitations of echocardiography in determining cardiac remodeling. Moscow.: Anacharsis 2007; 55 p. Russian (Васюк Ю.А., Хадзегова А.Б., Крикунов П.В. и др. Возможности и ограничения эхокардиографии в определении ремоделирования сердца. Москва: Анахарсис 2007; 55 с).

11. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106(25): 3143-421.

12. Chahal NS, Lim TK, Piyush Jain. Normative reference values for the tissue Doppler imaging parameters of left ventricular function: a population-based study. European J Echocardiography 2010; 11: 51-6.

13. Olivetti G, Melissari M, Capasso J, Anversa P. Cardiomyopathy of the aging human heart. Myocyte loss and reactive cellular hypertrophy. Circ Res 1991; 68: 1560-8.

14. Anisimov VN. Molecular and Physiological Mechanisms of Aging. 2 vol., 2nd ed., SPb: Publishing house. Nauka 2008; Vol. 1: 481 p. Russian (Анисимов В.Н. Молекулярные и физиологические механизмы старения. В 2т., 2-е изд., пере- раб. и доп. СПб.: Наука 2008; Т.1: 481 p).

15. Leri A, Franco S , Zacheo A, et al. Ablation of telomerase and telomere loss leads to cardiac dilatation and heart failure associated with p53 upregulation. EMBO J 2003; 22: 131-9.

16. Collerton J, Martin-Ruiz C, Kenny A, et al. Telomere length is associated with left ventricular function in the oldest old: the Newcastle 85+ study. Eur Heart J 2007; 28: 172-6.

17. Denil SL, Rietzschel ER, De Buyzere ML, et al. On cross-sectional associations of leukocyte telomere length with cardiac systolic, diastolic and vascular function: the Asklepios study. PLoS One 2014; 9(12): e115071.

18. Vasan RS, Demissie S, Kimura M, et al. Association of leukocyte telomere length with echocardiographic left ventricular mass: the Framingham heart study. Circulation 2009; 120(13): 1195-202.